1	Federal	_	JJ	_	_	3	NMOD	_	_
2	drug	_	NN	_	_	3	NMOD	_	_
3	regulators	_	NNS	_	_	21	SBJ	_	_
4	,	_	,	_	_	3	P	_	_
5	concerned	_	VBN	_	_	3	APPO	_	_
6	over	_	IN	_	_	5	AMOD	_	_
7	British	_	JJ	_	_	8	NMOD	_	_
8	reports	_	NNS	_	_	6	PMOD	_	_
9	that	_	IN	_	_	8	NMOD	_	_
10	diabetics	_	NNS	_	_	11	SBJ	_	_
11	have	_	VBP	_	_	9	SUB	_	_
12	died	_	VBN	_	_	11	VC	_	_
13	after	_	IN	_	_	12	TMP	_	_
14	shifting	_	VBG	_	_	13	PMOD	_	_
15	from	_	IN	_	_	14	ADV	_	_
16	animal	_	JJ	_	_	15	PMOD	_	_
17	to	_	TO	_	_	14	ADV	_	_
18	human-based	_	JJ	_	_	19	NMOD	_	_
19	insulin	_	NN	_	_	17	PMOD	_	_
20	,	_	,	_	_	3	P	_	_
21	say	_	VBP	_	_	0	ROOT	_	_
22	they	_	PRP	_	_	23	SBJ	_	_
23	are	_	VBP	_	_	21	OBJ	_	_
24	considering	_	VBG	_	_	23	VC	_	_
25	a	_	DT	_	_	26	NMOD	_	_
26	study	_	NN	_	_	24	OBJ	_	_
27	to	_	TO	_	_	26	NMOD	_	_
28	see	_	VB	_	_	27	IM	_	_
29	if	_	IN	_	_	28	OBJ	_	_
30	similar	_	JJ	_	_	31	NMOD	_	_
31	deaths	_	NNS	_	_	32	SBJ	_	_
32	have	_	VB	_	_	29	SUB	_	_
33	occurred	_	VBN	_	_	32	VC	_	_
34	here	_	RB	_	_	33	LOC	_	_
35	.	_	.	_	_	21	P	_	_

1	The	_	DT	_	_	4	NMOD	_	_
2	United	_	NNP	_	_	4	NMOD	_	_
3	Kingdom	_	NNP	_	_	4	NMOD	_	_
4	reports	_	NNS	_	_	5	SBJ	_	_
5	came	_	VBD	_	_	0	ROOT	_	_
6	from	_	IN	_	_	5	DIR	_	_
7	Dr.	_	NNP	_	_	9	TITLE	_	_
8	Patrick	_	NNP	_	_	9	NAME	_	_
9	Toseland	_	NNP	_	_	6	PMOD	_	_
10	,	_	,	_	_	9	P	_	_
11	head	_	NN	_	_	9	APPO	_	_
12	of	_	IN	_	_	11	NMOD	_	_
13	clinical	_	JJ	_	_	14	NMOD	_	_
14	chemistry	_	NN	_	_	12	PMOD	_	_
15	at	_	IN	_	_	11	LOC	_	_
16	Guy	_	NNP	_	_	18	NMOD	_	_
17	's	_	POS	_	_	16	SUFFIX	_	_
18	Hospital	_	NNP	_	_	15	PMOD	_	_
19	in	_	IN	_	_	18	LOC	_	_
20	London	_	NNP	_	_	19	PMOD	_	_
21	.	_	.	_	_	5	P	_	_

1	In	_	IN	_	_	9	LOC	_	_
2	a	_	DT	_	_	4	NMOD	_	_
3	telephone	_	NN	_	_	4	NMOD	_	_
4	interview	_	NN	_	_	1	PMOD	_	_
5	Friday	_	NNP	_	_	9	TMP	_	_
6	,	_	,	_	_	9	P	_	_
7	Dr.	_	NNP	_	_	8	TITLE	_	_
8	Toseland	_	NNP	_	_	9	SBJ	_	_
9	said	_	VBD	_	_	0	ROOT	_	_
10	the	_	DT	_	_	11	NMOD	_	_
11	number	_	NN	_	_	24	SBJ	_	_
12	of	_	IN	_	_	11	NMOD	_	_
13	sudden	_	JJ	_	_	16	NMOD	_	_
14	,	_	,	_	_	16	P	_	_
15	unexplained	_	JJ	_	_	16	NMOD	_	_
16	deaths	_	NNS	_	_	12	PMOD	_	_
17	of	_	IN	_	_	16	NMOD	_	_
18	diabetics	_	NNS	_	_	17	PMOD	_	_
19	he	_	PRP	_	_	20	SBJ	_	_
20	had	_	VBD	_	_	11	NMOD	_	_
21	seen	_	VBN	_	_	20	VC	_	_
22	this	_	DT	_	_	23	NMOD	_	_
23	year	_	NN	_	_	21	TMP	_	_
24	was	_	VBD	_	_	9	OBJ	_	_
25	17	_	CD	_	_	24	PRD	_	_
26	compared	_	VBN	_	_	25	NMOD	_	_
27	with	_	IN	_	_	26	PMOD	_	_
28	just	_	RB	_	_	29	NMOD	_	_
29	two	_	CD	_	_	27	PMOD	_	_
30	in	_	IN	_	_	29	TMP	_	_
31	1985	_	CD	_	_	30	PMOD	_	_
32	.	_	.	_	_	9	P	_	_

1	At	_	IN	_	_	3	DEP	_	_
2	least	_	JJS	_	_	3	DEP	_	_
3	six	_	CD	_	_	7	SBJ	_	_
4	of	_	IN	_	_	3	NMOD	_	_
5	the	_	DT	_	_	6	NMOD	_	_
6	deaths	_	NNS	_	_	4	PMOD	_	_
7	occurred	_	VBD	_	_	26	OBJ	_	_
8	among	_	IN	_	_	7	LOC	_	_
9	relatively	_	RB	_	_	10	AMOD	_	_
10	young	_	JJ	_	_	11	NMOD	_	_
11	diabetics	_	NNS	_	_	8	PMOD	_	_
12	who	_	WP	_	_	13	SBJ	_	_
13	had	_	VBD	_	_	11	NMOD	_	_
14	switched	_	VBN	_	_	13	VC	_	_
15	from	_	IN	_	_	14	ADV	_	_
16	animal	_	NN	_	_	15	PMOD	_	_
17	to	_	TO	_	_	14	ADV	_	_
18	human	_	JJ	_	_	19	NMOD	_	_
19	insulin	_	NN	_	_	17	PMOD	_	_
20	within	_	IN	_	_	14	TMP	_	_
21	the	_	DT	_	_	23	NMOD	_	_
22	past	_	JJ	_	_	23	NMOD	_	_
23	year	_	NN	_	_	20	PMOD	_	_
24	,	_	,	_	_	26	P	_	_
25	he	_	PRP	_	_	26	SBJ	_	_
26	said	_	VBD	_	_	0	ROOT	_	_
27	.	_	.	_	_	26	P	_	_

1	Dr.	_	NNP	_	_	3	TITLE	_	_
2	Solomon	_	NNP	_	_	3	NAME	_	_
3	Sobel	_	NNP	_	_	20	SBJ	_	_
4	,	_	,	_	_	3	P	_	_
5	director	_	NN	_	_	3	APPO	_	_
6	of	_	IN	_	_	5	NMOD	_	_
7	metabolism	_	NN	_	_	6	PMOD	_	_
8	and	_	CC	_	_	7	COORD	_	_
9	endrocrine	_	JJ	_	_	11	NMOD	_	_
10	drug	_	NN	_	_	11	NMOD	_	_
11	products	_	NNS	_	_	8	CONJ	_	_
12	for	_	IN	_	_	5	NMOD	_	_
13	the	_	DT	_	_	15	NMOD	_	_
14	U.S.	_	NNP	_	_	15	NAME	_	_
15	Food	_	NNP	_	_	12	PMOD	_	_
16	and	_	CC	_	_	15	COORD	_	_
17	Drug	_	NNP	_	_	18	NAME	_	_
18	Administration	_	NNP	_	_	16	CONJ	_	_
19	,	_	,	_	_	3	P	_	_
20	said	_	VBD	_	_	0	ROOT	_	_
21	FDA	_	NNP	_	_	22	NMOD	_	_
22	officials	_	NNS	_	_	23	SBJ	_	_
23	have	_	VBP	_	_	20	OBJ	_	_
24	discussed	_	VBN	_	_	23	VC	_	_
25	Dr.	_	NNP	_	_	26	TITLE	_	_
26	Toseland	_	NNP	_	_	28	NMOD	_	_
27	's	_	POS	_	_	26	SUFFIX	_	_
28	findings	_	NNS	_	_	24	OBJ	_	_
29	``	_	``	_	_	24	P	_	_
30	fairly	_	RB	_	_	24	MNR	_	_
31	intensively	_	RB	_	_	30	AMOD	_	_
32	.	_	.	_	_	20	P	_	_
33	''	_	''	_	_	20	P	_	_

1	While	_	IN	_	_	20	ADV	_	_
2	there	_	EX	_	_	3	SBJ	_	_
3	have	_	VBP	_	_	1	SUB	_	_
4	been	_	VBN	_	_	3	VC	_	_
5	no	_	DT	_	_	6	NMOD	_	_
6	reports	_	NNS	_	_	4	PRD	_	_
7	of	_	IN	_	_	6	NMOD	_	_
8	similar	_	JJ	_	_	11	NMOD	_	_
9	sudden	_	JJ	_	_	11	NMOD	_	_
10	unexplained	_	JJ	_	_	11	NMOD	_	_
11	deaths	_	NNS	_	_	7	PMOD	_	_
12	among	_	IN	_	_	11	LOC	_	_
13	diabetics	_	NNS	_	_	12	PMOD	_	_
14	in	_	IN	_	_	13	LOC	_	_
15	the	_	DT	_	_	16	NMOD	_	_
16	U.S.	_	NNP	_	_	14	PMOD	_	_
17	,	_	,	_	_	20	P	_	_
18	Dr.	_	NNP	_	_	19	TITLE	_	_
19	Sobel	_	NNP	_	_	20	SBJ	_	_
20	said	_	VBD	_	_	0	ROOT	_	_
21	the	_	DT	_	_	22	NMOD	_	_
22	FDA	_	NNP	_	_	23	SBJ	_	_
23	plans	_	NNS	_	_	20	OBJ	_	_
24	to	_	TO	_	_	23	OPRD	_	_
25	examine	_	VB	_	_	24	IM	_	_
26	Dr.	_	NNP	_	_	27	TITLE	_	_
27	Toseland	_	NNP	_	_	29	NMOD	_	_
28	's	_	POS	_	_	27	SUFFIX	_	_
29	evidence	_	NN	_	_	25	OBJ	_	_
30	and	_	CC	_	_	23	COORD	_	_
31	is	_	VBZ	_	_	30	CONJ	_	_
32	considering	_	VBG	_	_	31	VC	_	_
33	its	_	PRP$	_	_	35	NMOD	_	_
34	own	_	JJ	_	_	35	NMOD	_	_
35	study	_	NN	_	_	32	OBJ	_	_
36	here	_	RB	_	_	35	LOC	_	_
37	.	_	.	_	_	20	P	_	_

1	Dr.	_	NNP	_	_	2	TITLE	_	_
2	Toseland	_	NNP	_	_	7	SBJ	_	_
3	,	_	,	_	_	2	P	_	_
4	a	_	DT	_	_	5	NMOD	_	_
5	toxicologist	_	NN	_	_	2	APPO	_	_
6	,	_	,	_	_	2	P	_	_
7	said	_	VBD	_	_	0	ROOT	_	_
8	he	_	PRP	_	_	9	SBJ	_	_
9	was	_	VBD	_	_	7	OBJ	_	_
10	preparing	_	VBG	_	_	9	VC	_	_
11	an	_	DT	_	_	12	NMOD	_	_
12	article	_	NN	_	_	10	OBJ	_	_
13	for	_	IN	_	_	10	ADV	_	_
14	a	_	DT	_	_	18	NMOD	_	_
15	British	_	JJ	_	_	18	NMOD	_	_
16	forensic	_	JJ	_	_	18	NMOD	_	_
17	medical	_	JJ	_	_	18	NMOD	_	_
18	journal	_	NN	_	_	13	PMOD	_	_
19	raising	_	VBG	_	_	10	ADV	_	_
20	the	_	DT	_	_	21	NMOD	_	_
21	possibility	_	NN	_	_	19	OBJ	_	_
22	that	_	IN	_	_	21	NMOD	_	_
23	the	_	DT	_	_	24	NMOD	_	_
24	deaths	_	NNS	_	_	25	SBJ	_	_
25	may	_	MD	_	_	22	SUB	_	_
26	have	_	VB	_	_	25	VC	_	_
27	occurred	_	VBN	_	_	26	VC	_	_
28	after	_	IN	_	_	27	TMP	_	_
29	human	_	JJ	_	_	30	NMOD	_	_
30	insulin	_	NN	_	_	31	SBJ	_	_
31	blunted	_	VBD	_	_	28	SUB	_	_
32	critical	_	JJ	_	_	34	NMOD	_	_
33	warning	_	NN	_	_	34	NMOD	_	_
34	signs	_	NNS	_	_	31	OBJ	_	_
35	indicating	_	VBG	_	_	34	APPO	_	_
36	hypoglycemia	_	NN	_	_	35	OBJ	_	_
37	,	_	,	_	_	36	P	_	_
38	or	_	CC	_	_	36	COORD	_	_
39	low	_	JJ	_	_	41	NMOD	_	_
40	blood	_	NN	_	_	41	NMOD	_	_
41	sugar	_	NN	_	_	38	CONJ	_	_
42	,	_	,	_	_	36	P	_	_
43	which	_	WDT	_	_	44	SBJ	_	_
44	can	_	MD	_	_	36	NMOD	_	_
45	kill	_	VB	_	_	44	VC	_	_
46	diabetics	_	NNS	_	_	45	OBJ	_	_
47	.	_	.	_	_	7	P	_	_

1	The	_	DT	_	_	4	NMOD	_	_
2	usual	_	JJ	_	_	4	NMOD	_	_
3	warning	_	NN	_	_	4	NMOD	_	_
4	signs	_	NNS	_	_	7	SBJ	_	_
5	of	_	IN	_	_	4	NMOD	_	_
6	hypoglycemia	_	NN	_	_	5	PMOD	_	_
7	include	_	VBP	_	_	0	ROOT	_	_
8	sweating	_	NN	_	_	7	OBJ	_	_
9	,	_	,	_	_	8	P	_	_
10	anxiety	_	NN	_	_	8	COORD	_	_
11	and	_	CC	_	_	10	COORD	_	_
12	cramps	_	NNS	_	_	11	CONJ	_	_
13	.	_	.	_	_	7	P	_	_

1	With	_	IN	_	_	6	ADV	_	_
2	proper	_	JJ	_	_	3	NMOD	_	_
3	warning	_	NN	_	_	1	PMOD	_	_
4	,	_	,	_	_	6	P	_	_
5	diabetics	_	NNS	_	_	6	SBJ	_	_
6	can	_	MD	_	_	0	ROOT	_	_
7	easily	_	RB	_	_	8	MNR	_	_
8	raise	_	VB	_	_	6	VC	_	_
9	their	_	PRP$	_	_	11	NMOD	_	_
10	blood	_	NN	_	_	11	NMOD	_	_
11	sugar	_	NN	_	_	8	OBJ	_	_
12	to	_	TO	_	_	8	ADV	_	_
13	safe	_	JJ	_	_	14	NMOD	_	_
14	levels	_	NNS	_	_	12	PMOD	_	_
15	by	_	IN	_	_	8	MNR	_	_
16	eating	_	VBG	_	_	15	PMOD	_	_
17	sugar	_	NN	_	_	16	OBJ	_	_
18	or	_	CC	_	_	17	COORD	_	_
19	sugary	_	JJ	_	_	20	NMOD	_	_
20	food	_	NN	_	_	18	CONJ	_	_
21	.	_	.	_	_	6	P	_	_

1	``	_	``	_	_	25	P	_	_
2	The	_	DT	_	_	4	NMOD	_	_
3	anecdotal	_	JJ	_	_	4	NMOD	_	_
4	data	_	NN	_	_	6	SBJ	_	_
5	certainly	_	RB	_	_	6	ADV	_	_
6	shows	_	VBZ	_	_	25	OBJ	_	_
7	that	_	IN	_	_	6	OBJ	_	_
8	some	_	DT	_	_	12	SBJ	_	_
9	of	_	IN	_	_	8	NMOD	_	_
10	the	_	DT	_	_	11	NMOD	_	_
11	people	_	NNS	_	_	9	PMOD	_	_
12	were	_	VBD	_	_	7	SUB	_	_
13	not	_	RB	_	_	12	ADV	_	_
14	aware	_	JJ	_	_	12	PRD	_	_
15	of	_	IN	_	_	14	AMOD	_	_
16	the	_	DT	_	_	18	NMOD	_	_
17	rapid	_	JJ	_	_	18	NMOD	_	_
18	onset	_	NN	_	_	15	PMOD	_	_
19	of	_	IN	_	_	18	NMOD	_	_
20	hypoglycemia	_	NN	_	_	19	PMOD	_	_
21	,	_	,	_	_	25	P	_	_
22	''	_	''	_	_	25	P	_	_
23	Dr.	_	NNP	_	_	24	TITLE	_	_
24	Toseland	_	NNP	_	_	25	SBJ	_	_
25	said	_	VBD	_	_	0	ROOT	_	_
26	.	_	.	_	_	25	P	_	_

1	At	_	IN	_	_	21	LOC	_	_
2	the	_	DT	_	_	5	NMOD	_	_
3	U.S.	_	NNP	_	_	5	NAME	_	_
4	National	_	NNP	_	_	5	NAME	_	_
5	Institutes	_	NNP	_	_	1	PMOD	_	_
6	of	_	IN	_	_	5	NMOD	_	_
7	Health	_	NNP	_	_	6	PMOD	_	_
8	,	_	,	_	_	21	P	_	_
9	Dr.	_	NNP	_	_	12	TITLE	_	_
10	Robert	_	NNP	_	_	12	NAME	_	_
11	E.	_	NNP	_	_	12	NAME	_	_
12	Silverman	_	NNP	_	_	21	SBJ	_	_
13	,	_	,	_	_	12	P	_	_
14	chief	_	NN	_	_	12	APPO	_	_
15	of	_	IN	_	_	14	NMOD	_	_
16	the	_	DT	_	_	19	NMOD	_	_
17	diabetes	_	NN	_	_	19	NMOD	_	_
18	program	_	NN	_	_	19	NMOD	_	_
19	branch	_	NN	_	_	15	PMOD	_	_
20	,	_	,	_	_	12	P	_	_
21	said	_	VBD	_	_	0	ROOT	_	_
22	no	_	DT	_	_	23	NMOD	_	_
23	evidence	_	NN	_	_	29	SBJ	_	_
24	of	_	IN	_	_	23	NMOD	_	_
25	unexpected	_	JJ	_	_	26	NMOD	_	_
26	deaths	_	NNS	_	_	24	PMOD	_	_
27	from	_	IN	_	_	26	NMOD	_	_
28	hypoglycemia	_	NN	_	_	27	PMOD	_	_
29	had	_	VBD	_	_	21	OBJ	_	_
30	shown	_	VBN	_	_	29	VC	_	_
31	up	_	RP	_	_	30	PRT	_	_
32	in	_	IN	_	_	30	LOC	_	_
33	a	_	DT	_	_	34	NMOD	_	_
34	study	_	NN	_	_	32	PMOD	_	_
35	of	_	IN	_	_	34	NMOD	_	_
36	1,500	_	CD	_	_	37	NMOD	_	_
37	diabetics	_	NNS	_	_	35	PMOD	_	_
38	that	_	WDT	_	_	39	SBJ	_	_
39	has	_	VBZ	_	_	34	NMOD	_	_
40	been	_	VBN	_	_	39	VC	_	_
41	under	_	IN	_	_	40	PRD	_	_
42	way	_	NN	_	_	41	PMOD	_	_
43	at	_	IN	_	_	40	LOC	_	_
44	NIH	_	NNP	_	_	43	PMOD	_	_
45	for	_	IN	_	_	40	TMP	_	_
46	five	_	CD	_	_	47	NMOD	_	_
47	years	_	NNS	_	_	45	PMOD	_	_
48	.	_	.	_	_	21	P	_	_

1	However	_	RB	_	_	4	ADV	_	_
2	,	_	,	_	_	4	P	_	_
3	he	_	PRP	_	_	4	SBJ	_	_
4	said	_	VBD	_	_	0	ROOT	_	_
5	officials	_	NNS	_	_	9	SBJ	_	_
6	conducting	_	VBG	_	_	5	APPO	_	_
7	the	_	DT	_	_	8	NMOD	_	_
8	study	_	NN	_	_	6	OBJ	_	_
9	had	_	VBD	_	_	4	OBJ	_	_
10	n't	_	RB	_	_	9	ADV	_	_
11	been	_	VBN	_	_	9	VC	_	_
12	looking	_	VBG	_	_	11	VC	_	_
13	for	_	IN	_	_	12	ADV	_	_
14	signs	_	NNS	_	_	13	PMOD	_	_
15	of	_	IN	_	_	14	NMOD	_	_
16	problems	_	NNS	_	_	15	PMOD	_	_
17	related	_	VBN	_	_	16	APPO	_	_
18	to	_	TO	_	_	17	AMOD	_	_
19	hypoglycemia	_	NN	_	_	20	NMOD	_	_
20	unawareness	_	NN	_	_	18	PMOD	_	_
21	.	_	.	_	_	4	P	_	_

1	``	_	``	_	_	14	P	_	_
2	We	_	PRP	_	_	3	SBJ	_	_
3	are	_	VBP	_	_	14	OBJ	_	_
4	now	_	RB	_	_	3	TMP	_	_
5	monitoring	_	VBG	_	_	3	VC	_	_
6	for	_	IN	_	_	5	ADV	_	_
7	it	_	PRP	_	_	6	PMOD	_	_
8	much	_	RB	_	_	5	MNR	_	_
9	more	_	RBR	_	_	8	AMOD	_	_
10	closely	_	RB	_	_	8	AMOD	_	_
11	,	_	,	_	_	14	P	_	_
12	''	_	''	_	_	14	P	_	_
13	he	_	PRP	_	_	14	SBJ	_	_
14	said	_	VBD	_	_	0	ROOT	_	_
15	.	_	.	_	_	14	P	_	_

1	``	_	``	_	_	24	P	_	_
2	We	_	PRP	_	_	3	SBJ	_	_
3	do	_	VBP	_	_	24	OBJ	_	_
4	know	_	VB	_	_	3	VC	_	_
5	there	_	EX	_	_	6	SBJ	_	_
6	are	_	VBP	_	_	4	OBJ	_	_
7	slight	_	JJ	_	_	8	NMOD	_	_
8	differences	_	NNS	_	_	6	PRD	_	_
9	in	_	IN	_	_	8	LOC	_	_
10	the	_	DT	_	_	11	NMOD	_	_
11	way	_	NN	_	_	9	PMOD	_	_
12	human	_	JJ	_	_	15	NMOD	_	_
13	and	_	CC	_	_	12	COORD	_	_
14	animal	_	JJ	_	_	13	CONJ	_	_
15	insulins	_	NNS	_	_	16	SBJ	_	_
16	drive	_	VBP	_	_	11	NMOD	_	_
17	down	_	RP	_	_	16	PRT	_	_
18	blood	_	NN	_	_	19	NMOD	_	_
19	sugar	_	NN	_	_	16	OBJ	_	_
20	,	_	,	_	_	24	P	_	_
21	''	_	''	_	_	24	P	_	_
22	Dr.	_	NNP	_	_	23	TITLE	_	_
23	Sobel	_	NNP	_	_	24	SBJ	_	_
24	said	_	VBD	_	_	0	ROOT	_	_
25	.	_	.	_	_	24	P	_	_

1	The	_	DT	_	_	3	NMOD	_	_
2	human-based	_	JJ	_	_	3	NMOD	_	_
3	drug	_	NN	_	_	4	SBJ	_	_
4	starts	_	VBZ	_	_	17	OBJ	_	_
5	the	_	DT	_	_	7	NMOD	_	_
6	blood	_	NN	_	_	7	NMOD	_	_
7	sugar	_	NN	_	_	4	OBJ	_	_
8	dropping	_	VBG	_	_	7	NMOD	_	_
9	sooner	_	RBR	_	_	4	TMP	_	_
10	and	_	CC	_	_	4	COORD	_	_
11	drives	_	VBZ	_	_	10	CONJ	_	_
12	it	_	PRP	_	_	11	OBJ	_	_
13	down	_	RP	_	_	11	PRT	_	_
14	faster	_	RBR	_	_	11	MNR	_	_
15	,	_	,	_	_	17	P	_	_
16	he	_	PRP	_	_	17	SBJ	_	_
17	said	_	VBD	_	_	0	ROOT	_	_
18	.	_	.	_	_	17	P	_	_

1	``	_	``	_	_	21	P	_	_
2	But	_	CC	_	_	4	DEP	_	_
3	we	_	PRP	_	_	4	SBJ	_	_
4	do	_	VBP	_	_	21	OBJ	_	_
5	n't	_	RB	_	_	4	ADV	_	_
6	believe	_	VB	_	_	4	VC	_	_
7	there	_	EX	_	_	8	SBJ	_	_
8	is	_	VBZ	_	_	6	OBJ	_	_
9	enough	_	JJ	_	_	8	PRD	_	_
10	of	_	IN	_	_	9	AMOD	_	_
11	a	_	DT	_	_	12	NMOD	_	_
12	difference	_	NN	_	_	10	PMOD	_	_
13	to	_	TO	_	_	9	AMOD	_	_
14	be	_	VB	_	_	13	IM	_	_
15	clinically	_	RB	_	_	16	AMOD	_	_
16	significant	_	JJ	_	_	14	PRD	_	_
17	,	_	,	_	_	21	P	_	_
18	''	_	''	_	_	21	P	_	_
19	Dr.	_	NNP	_	_	20	TITLE	_	_
20	Sobel	_	NNP	_	_	21	SBJ	_	_
21	said	_	VBD	_	_	0	ROOT	_	_
22	.	_	.	_	_	21	P	_	_

1	Reports	_	NNS	_	_	11	SBJ	_	_
2	of	_	IN	_	_	1	NMOD	_	_
3	Dr.	_	NNP	_	_	4	TITLE	_	_
4	Toseland	_	NNP	_	_	6	NMOD	_	_
5	's	_	POS	_	_	4	SUFFIX	_	_
6	findings	_	NNS	_	_	2	PMOD	_	_
7	in	_	IN	_	_	1	LOC	_	_
8	the	_	DT	_	_	10	NMOD	_	_
9	British	_	JJ	_	_	10	NMOD	_	_
10	press	_	NN	_	_	7	PMOD	_	_
11	have	_	VBP	_	_	0	ROOT	_	_
12	triggered	_	VBN	_	_	11	VC	_	_
13	widespread	_	JJ	_	_	14	NMOD	_	_
14	concern	_	NN	_	_	12	OBJ	_	_
15	among	_	IN	_	_	12	LOC	_	_
16	diabetics	_	NNS	_	_	15	PMOD	_	_
17	there	_	RB	_	_	16	LOC	_	_
18	.	_	.	_	_	11	P	_	_

1	Both	_	DT	_	_	5	NMOD	_	_
2	the	_	DT	_	_	5	NMOD	_	_
3	British	_	NNP	_	_	5	NAME	_	_
4	Diabetic	_	NNP	_	_	5	NAME	_	_
5	Association	_	NNP	_	_	23	SBJ	_	_
6	and	_	CC	_	_	5	COORD	_	_
7	the	_	DT	_	_	8	NMOD	_	_
8	Committee	_	NNP	_	_	6	CONJ	_	_
9	on	_	IN	_	_	8	NMOD	_	_
10	Safety	_	NNP	_	_	9	PMOD	_	_
11	in	_	IN	_	_	10	LOC	_	_
12	Medicines	_	NNP	_	_	11	PMOD	_	_
13	--	_	:	_	_	16	P	_	_
14	Britain	_	NNP	_	_	16	NMOD	_	_
15	's	_	POS	_	_	14	SUFFIX	_	_
16	equivalent	_	NN	_	_	8	PRN	_	_
17	of	_	IN	_	_	16	NMOD	_	_
18	the	_	DT	_	_	20	NMOD	_	_
19	U.S.	_	NNP	_	_	20	NAME	_	_
20	FDA	_	NNP	_	_	17	PMOD	_	_
21	--	_	:	_	_	16	P	_	_
22	recently	_	RB	_	_	23	TMP	_	_
23	issued	_	VBD	_	_	0	ROOT	_	_
24	statements	_	NNS	_	_	23	OBJ	_	_
25	noting	_	VBG	_	_	24	APPO	_	_
26	the	_	DT	_	_	27	NMOD	_	_
27	lack	_	NN	_	_	25	OBJ	_	_
28	of	_	IN	_	_	27	NMOD	_	_
29	hard	_	JJ	_	_	31	NMOD	_	_
30	scientific	_	JJ	_	_	31	NMOD	_	_
31	evidence	_	NN	_	_	28	PMOD	_	_
32	to	_	TO	_	_	31	NMOD	_	_
33	support	_	VB	_	_	32	IM	_	_
34	Dr.	_	NNP	_	_	35	TITLE	_	_
35	Toseland	_	NNP	_	_	37	NMOD	_	_
36	's	_	POS	_	_	35	SUFFIX	_	_
37	findings	_	NNS	_	_	33	OBJ	_	_
38	.	_	.	_	_	23	P	_	_

1	On	_	IN	_	_	8	TMP	_	_
2	Friday	_	NNP	_	_	1	PMOD	_	_
3	,	_	,	_	_	8	P	_	_
4	the	_	DT	_	_	7	NMOD	_	_
5	American	_	NNP	_	_	7	NAME	_	_
6	Diabetes	_	NNP	_	_	7	NAME	_	_
7	Association	_	NNP	_	_	8	SBJ	_	_
8	issued	_	VBD	_	_	0	ROOT	_	_
9	a	_	DT	_	_	11	NMOD	_	_
10	similar	_	JJ	_	_	11	NMOD	_	_
11	statement	_	NN	_	_	8	OBJ	_	_
12	urging	_	VBG	_	_	11	APPO	_	_
13	the	_	DT	_	_	17	NMOD	_	_
14	six	_	CD	_	_	15	DEP	_	_
15	million	_	CD	_	_	17	NMOD	_	_
16	U.S.	_	NNP	_	_	17	NMOD	_	_
17	diabetics	_	NNS	_	_	12	OBJ	_	_
18	not	_	RB	_	_	19	ADV	_	_
19	to	_	TO	_	_	12	OPRD	_	_
20	overreact	_	VB	_	_	19	IM	_	_
21	to	_	TO	_	_	20	ADV	_	_
22	the	_	DT	_	_	24	NMOD	_	_
23	British	_	JJ	_	_	24	NMOD	_	_
24	report	_	NN	_	_	21	PMOD	_	_
25	.	_	.	_	_	8	P	_	_

1	``	_	``	_	_	33	P	_	_
2	A	_	DT	_	_	3	NMOD	_	_
3	loss	_	NN	_	_	10	SBJ	_	_
4	of	_	IN	_	_	3	NMOD	_	_
5	the	_	DT	_	_	7	NMOD	_	_
6	warning	_	NN	_	_	7	NMOD	_	_
7	symptoms	_	NNS	_	_	4	PMOD	_	_
8	of	_	IN	_	_	7	NMOD	_	_
9	hypoglycemia	_	NN	_	_	8	PMOD	_	_
10	is	_	VBZ	_	_	33	OBJ	_	_
11	a	_	DT	_	_	13	NMOD	_	_
12	complex	_	JJ	_	_	13	NMOD	_	_
13	problem	_	NN	_	_	10	PRD	_	_
14	that	_	WDT	_	_	15	SBJ	_	_
15	is	_	VBZ	_	_	13	NMOD	_	_
16	very	_	RB	_	_	17	AMOD	_	_
17	unlikely	_	JJ	_	_	15	PRD	_	_
18	to	_	TO	_	_	17	AMOD	_	_
19	be	_	VB	_	_	18	IM	_	_
20	due	_	RB	_	_	19	PRD	_	_
21	simply	_	RB	_	_	22	PMOD	_	_
22	to	_	TO	_	_	20	AMOD	_	_
23	the	_	DT	_	_	24	NMOD	_	_
24	type	_	NN	_	_	22	PMOD	_	_
25	of	_	IN	_	_	24	NMOD	_	_
26	insulin	_	NN	_	_	25	PMOD	_	_
27	used	_	VBN	_	_	24	APPO	_	_
28	,	_	,	_	_	33	P	_	_
29	''	_	''	_	_	33	P	_	_
30	the	_	DT	_	_	32	NMOD	_	_
31	American	_	JJ	_	_	32	NMOD	_	_
32	association	_	NN	_	_	33	SBJ	_	_
33	said	_	VBD	_	_	0	ROOT	_	_
34	.	_	.	_	_	33	P	_	_

1	The	_	DT	_	_	2	NMOD	_	_
2	FDA	_	NNP	_	_	4	SBJ	_	_
3	already	_	RB	_	_	4	TMP	_	_
4	requires	_	VBZ	_	_	0	ROOT	_	_
5	drug	_	NN	_	_	6	NMOD	_	_
6	manufacturers	_	NNS	_	_	4	OBJ	_	_
7	to	_	TO	_	_	4	OPRD	_	_
8	include	_	VB	_	_	7	IM	_	_
9	warnings	_	NNS	_	_	8	OBJ	_	_
10	with	_	IN	_	_	8	ADV	_	_
11	insulin	_	NN	_	_	12	NMOD	_	_
12	products	_	NNS	_	_	10	PMOD	_	_
13	that	_	IN	_	_	9	NMOD	_	_
14	symptoms	_	NNS	_	_	17	SBJ	_	_
15	of	_	IN	_	_	14	NMOD	_	_
16	hypoglycemia	_	NN	_	_	15	PMOD	_	_
17	are	_	VBP	_	_	13	SUB	_	_
18	less	_	RBR	_	_	19	AMOD	_	_
19	pronounced	_	JJ	_	_	17	PRD	_	_
20	with	_	IN	_	_	19	AMOD	_	_
21	human	_	JJ	_	_	22	NMOD	_	_
22	insulin	_	NN	_	_	20	PMOD	_	_
23	than	_	IN	_	_	19	AMOD	_	_
24	with	_	IN	_	_	23	PMOD	_	_
25	animal-based	_	JJ	_	_	26	NMOD	_	_
26	products	_	NNS	_	_	24	PMOD	_	_
27	.	_	.	_	_	4	P	_	_

1	Eli	_	NNP	_	_	2	NAME	_	_
2	Lilly	_	NNP	_	_	11	SBJ	_	_
3	&	_	CC	_	_	2	COORD	_	_
4	Co.	_	NNP	_	_	3	CONJ	_	_
5	,	_	,	_	_	2	P	_	_
6	the	_	DT	_	_	9	NMOD	_	_
7	Indianapolis-based	_	JJ	_	_	9	NMOD	_	_
8	drug	_	NN	_	_	9	NMOD	_	_
9	manufacturer	_	NN	_	_	2	APPO	_	_
10	,	_	,	_	_	2	P	_	_
11	dominates	_	VBZ	_	_	0	ROOT	_	_
12	the	_	DT	_	_	16	NMOD	_	_
13	U.S.	_	NNP	_	_	16	NMOD	_	_
14	human	_	JJ	_	_	16	NMOD	_	_
15	insulin	_	NN	_	_	16	NMOD	_	_
16	market	_	NN	_	_	11	OBJ	_	_
17	with	_	IN	_	_	11	ADV	_	_
18	its	_	PRP$	_	_	19	NMOD	_	_
19	product	_	NN	_	_	17	PMOD	_	_
20	known	_	VBN	_	_	19	APPO	_	_
21	as	_	IN	_	_	20	ADV	_	_
22	Humulin	_	NNP	_	_	21	PMOD	_	_
23	.	_	.	_	_	11	P	_	_

1	Lilly	_	NNP	_	_	2	SBJ	_	_
2	is	_	VBZ	_	_	0	ROOT	_	_
3	building	_	VBG	_	_	2	VC	_	_
4	plants	_	NNS	_	_	3	OBJ	_	_
5	to	_	TO	_	_	4	NMOD	_	_
6	make	_	VB	_	_	5	IM	_	_
7	the	_	DT	_	_	8	NMOD	_	_
8	insulin	_	NN	_	_	6	OBJ	_	_
9	in	_	IN	_	_	3	LOC	_	_
10	Indianapolis	_	NNP	_	_	9	PMOD	_	_
11	and	_	CC	_	_	10	COORD	_	_
12	Fagershein	_	NNP	_	_	11	CONJ	_	_
13	,	_	,	_	_	12	P	_	_
14	France	_	NNP	_	_	12	LOC	_	_
15	.	_	.	_	_	2	P	_	_

1	In	_	IN	_	_	8	LOC	_	_
2	its	_	PRP$	_	_	5	NMOD	_	_
3	latest	_	JJS	_	_	5	NMOD	_	_
4	annual	_	JJ	_	_	5	NMOD	_	_
5	report	_	NN	_	_	1	PMOD	_	_
6	,	_	,	_	_	8	P	_	_
7	Lilly	_	NNP	_	_	8	SBJ	_	_
8	said	_	VBD	_	_	0	ROOT	_	_
9	Humulin	_	NNP	_	_	10	NMOD	_	_
10	sales	_	NNS	_	_	11	SBJ	_	_
11	have	_	VBP	_	_	8	OBJ	_	_
12	shown	_	VBN	_	_	11	VC	_	_
13	``	_	``	_	_	12	P	_	_
14	excellent	_	JJ	_	_	15	NMOD	_	_
15	growth	_	NN	_	_	12	OBJ	_	_
16	.	_	.	_	_	8	P	_	_
17	''	_	''	_	_	8	P	_	_

1	Lilly	_	NNP	_	_	2	NMOD	_	_
2	officials	_	NNS	_	_	3	SBJ	_	_
3	said	_	VBD	_	_	0	ROOT	_	_
4	they	_	PRP	_	_	5	SBJ	_	_
5	had	_	VBD	_	_	3	OBJ	_	_
6	seen	_	VBN	_	_	5	VC	_	_
7	reports	_	NNS	_	_	6	OBJ	_	_
8	of	_	IN	_	_	7	NMOD	_	_
9	hypoglycemic	_	JJ	_	_	10	NMOD	_	_
10	unawareness	_	NN	_	_	8	PMOD	_	_
11	among	_	IN	_	_	10	LOC	_	_
12	some	_	DT	_	_	13	NMOD	_	_
13	patients	_	NNS	_	_	11	PMOD	_	_
14	making	_	VBG	_	_	13	APPO	_	_
15	the	_	DT	_	_	16	NMOD	_	_
16	shift	_	NN	_	_	14	OBJ	_	_
17	from	_	IN	_	_	16	NMOD	_	_
18	animal	_	JJ	_	_	17	PMOD	_	_
19	to	_	TO	_	_	16	NMOD	_	_
20	human	_	JJ	_	_	21	NMOD	_	_
21	insulin	_	NN	_	_	19	PMOD	_	_
22	,	_	,	_	_	3	P	_	_
23	but	_	CC	_	_	3	COORD	_	_
24	did	_	VBD	_	_	23	CONJ	_	_
25	n't	_	RB	_	_	24	ADV	_	_
26	know	_	VB	_	_	24	VC	_	_
27	if	_	IN	_	_	26	OBJ	_	_
28	the	_	DT	_	_	29	NMOD	_	_
29	problem	_	NN	_	_	30	SBJ	_	_
30	had	_	VBD	_	_	27	SUB	_	_
31	caused	_	VBN	_	_	30	VC	_	_
32	any	_	DT	_	_	33	NMOD	_	_
33	deaths	_	NNS	_	_	31	OBJ	_	_
34	.	_	.	_	_	3	P	_	_

1	Dr.	_	NNP	_	_	3	TITLE	_	_
2	Leigh	_	NNP	_	_	3	NAME	_	_
3	Thompson	_	NNP	_	_	11	SBJ	_	_
4	,	_	,	_	_	3	P	_	_
5	a	_	DT	_	_	9	NMOD	_	_
6	Lilly	_	NNP	_	_	9	NMOD	_	_
7	group	_	NN	_	_	9	NMOD	_	_
8	vice	_	NN	_	_	9	NMOD	_	_
9	president	_	NN	_	_	3	APPO	_	_
10	,	_	,	_	_	3	P	_	_
11	said	_	VBD	_	_	0	ROOT	_	_
12	the	_	DT	_	_	13	NMOD	_	_
13	company	_	NN	_	_	16	NMOD	_	_
14	's	_	POS	_	_	13	SUFFIX	_	_
15	clinical	_	JJ	_	_	16	NMOD	_	_
16	trials	_	NNS	_	_	24	SBJ	_	_
17	of	_	IN	_	_	16	NMOD	_	_
18	both	_	CC	_	_	23	DEP	_	_
19	its	_	PRP$	_	_	23	NMOD	_	_
20	animal	_	JJ	_	_	23	NMOD	_	_
21	and	_	CC	_	_	20	COORD	_	_
22	human-based	_	JJ	_	_	21	CONJ	_	_
23	insulins	_	NNS	_	_	17	PMOD	_	_
24	indicated	_	VBD	_	_	11	OBJ	_	_
25	no	_	DT	_	_	26	NMOD	_	_
26	difference	_	NN	_	_	24	OBJ	_	_
27	in	_	IN	_	_	26	LOC	_	_
28	the	_	DT	_	_	29	NMOD	_	_
29	level	_	NN	_	_	27	PMOD	_	_
30	of	_	IN	_	_	29	NMOD	_	_
31	hypoglycemia	_	NN	_	_	30	PMOD	_	_
32	between	_	IN	_	_	26	LOC	_	_
33	users	_	NNS	_	_	32	PMOD	_	_
34	of	_	IN	_	_	33	NMOD	_	_
35	either	_	DT	_	_	36	NMOD	_	_
36	product	_	NN	_	_	34	PMOD	_	_
37	.	_	.	_	_	11	P	_	_

1	Dr.	_	NNP	_	_	2	TITLE	_	_
2	Toseland	_	NNP	_	_	3	SBJ	_	_
3	said	_	VBD	_	_	0	ROOT	_	_
4	most	_	JJS	_	_	11	SBJ	_	_
5	of	_	IN	_	_	4	NMOD	_	_
6	the	_	DT	_	_	8	NMOD	_	_
7	British	_	JJ	_	_	8	NMOD	_	_
8	diabetics	_	NNS	_	_	5	PMOD	_	_
9	who	_	WP	_	_	10	SBJ	_	_
10	died	_	VBD	_	_	4	NMOD	_	_
11	had	_	VBD	_	_	3	OBJ	_	_
12	been	_	VBN	_	_	11	VC	_	_
13	taking	_	VBG	_	_	12	VC	_	_
14	a	_	DT	_	_	16	NMOD	_	_
15	human-based	_	JJ	_	_	16	NMOD	_	_
16	insulin	_	NN	_	_	13	OBJ	_	_
17	made	_	VBN	_	_	16	APPO	_	_
18	by	_	IN	_	_	17	LGS	_	_
19	Novo	_	NNP	_	_	18	PMOD	_	_
20	/	_	CC	_	_	19	COORD	_	_
21	Nordisk	_	NNP	_	_	20	CONJ	_	_
22	,	_	,	_	_	19	P	_	_
23	a	_	DT	_	_	25	NMOD	_	_
24	Danish	_	JJ	_	_	25	NMOD	_	_
25	manufacturer	_	NN	_	_	19	APPO	_	_
26	.	_	.	_	_	3	P	_	_

1	None	_	NN	_	_	5	SBJ	_	_
2	of	_	IN	_	_	1	NMOD	_	_
3	the	_	DT	_	_	4	NMOD	_	_
4	diabetics	_	NNS	_	_	2	PMOD	_	_
5	were	_	VBD	_	_	0	ROOT	_	_
6	using	_	VBG	_	_	5	VC	_	_
7	Lilly	_	NNP	_	_	9	NMOD	_	_
8	's	_	POS	_	_	7	SUFFIX	_	_
9	insulin	_	NN	_	_	6	OBJ	_	_
10	.	_	.	_	_	5	P	_	_

